BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• 

  Deals

  Cardinal Health Unloads China Biz to Shanghai Pharma in $1.2B Deal

  The transaction is expected to close by the end of Cardinal Health’s fiscal year, subject to closing conditions and regulatory clearances.

  November 14, 2017

   · 

  5 min read
• Genetown

  Sage Therapeutics Prices Public Offering of Common Stock

  The offering is expected to close on or about November 17, 2017, subject to the satisfaction of customary closing conditions.

  November 14, 2017

   · 

  5 min read
• Business

  Pluristem Reports First Quarter Fiscal 2018 Corporate and Financial Highlights

  As of September 30, 2017, Pluristem had $21.3 million in cash and cash equivalents, bank deposits, restricted deposits and marketable securities.

  November 14, 2017

   · 

  7 min read
• BioCapital

  Neuronascent Granted Composition of Matter Patent in Europe for Oral Neuron Regenerative Technology

  The claims cover small molecule candidates and the family around these candidates and their human use, adding to the patent coverage in the US and elsewhere.

  November 14, 2017

   · 

  2 min read
• 

  Biotech Bay

  Bay Area’s EBR Systems Scores $50M to Complete Global Heart Failure Trial

  The financing was led by Australian private equity firms M.H. Carnegie & Co. and Brandon Capital Partners.

  November 14, 2017

   · 

  5 min read
• Business

  TearLab Corporation Reports Third Quarter and September Year-To-Date 2017 Financial Results

  For the three months ended September 30, 2017, TearLab’s net revenues were $6.5 million, compared with $7.2 million for the same period in 2016.

  November 14, 2017

   · 

  8 min read
• Business

  Krystal Biotech Reports that KB103 Received Clearance From RAC Review and Announces Third Quarter 2017 Financial Results

  Cash totaled $52.6 million at September 30, 2017.

  November 14, 2017

   · 

  8 min read
• MiMedx Adds New Materials to its Website Exposing Misinformation Disseminated Through Short Sellers

  MiMedx announced today that it has posted additional materials on the Company’s website that further expose the misinformation disseminated through short sellers.

  November 14, 2017

   · 

  3 min read
• BerGenBio to Present BGB324 and KEYTRUDA (pembrolizumab) Clinical Trial at the 2017 San Antonio Breast Cancer Symposium

  The poster presentation will describe the rationale and design of the combination study with KEYTRUDA and BGB324, a first-in-class and highly selective small molecule Axl kinase inhibitor, which is being developed to target tumour immune evasion and resistance.

  November 14, 2017

   · 

  1 min read
• Business

  Acura Pharmaceuticals Announces Third Quarter 2017 Financial Results

  The Company reported a net loss of $2.2 million or $0.12 per diluted share for quarter ended September 30, 2017 compared to a net loss of $2.3 million or $0.19 per diluted share for the same period in 2016.

  November 14, 2017

   · 

  8 min read